Advertisement
Home 2020

Archives

The National Institutes of Health announced Saturday that a clinical trial evaluating hydroxychloroquine for the treatment of COVID-19 has been stopped because the drug likely provides no benefit.

NIH Stops Hydroxychloroquine Trial

0
Although there was no harm, data and safety monitoring board found the drug 'very unlikely to be beneficial'
Two lots of Children's Robitussin Honey Cough and Chest Congestion DM and one lot of Children's Dimetapp Cold and Cough have been recalled because they have incorrect dosing cups that could put children at risk for an overdose.

Children’s Robitussin Honey Cough and Chest Congestion DM Recalled

0
Dosing cups missing some graduation markings
An inhaled version of the antiviral drug remdesivir will soon be tested outside a hospital setting

Inhaled Remdesivir May Allow COVID-19 Patients to Be Treated at Home

0
Currently, the drug has to be given intravenously through daily infusions in the hospital
A study on the use of masks to protect against the new coronavirus should be retracted by the Proceedings of the National Academy of Sciences because it contains "egregious errors" and "verifiably false" statements

Scientists Say Journal Should Retract Mask Study

0
Study, published June 11, claims wearing a mask 'significantly reduces the number of infections' with the new coronavirus
Antiracism protests in the United States have not led to increases in new cases of the coronavirus that causes COVID-19

Early Data Show No Protest-Related Increases in COVID-19 Infections

0
Use of masks and the fact that protests are outdoors may have helped
The U.S. government does not have the legal authority to force drug companies to disclose prices in their TV ads

Court Rules Against Drug Price Disclosures in TV Ads

0
Judges said HHS exceeded its legal authority by requiring drug price disclosure as part of its stewardship of Medicare, Medicaid
Mayors in Houston

Nine Texas Mayors Ask Governor for Power to Mandate Face Masks

0
Growing number of studies show face masks reduce the spread of the new coronavirus
Health insurance companies are expected to cover vaccines for the new coronavirus without charging copays

U.S. Insurers Should Not Charge Copays for COVID-19 Vaccine

0
Government has been in discussions with insurers about covering COVID-19 vaccination at no cost to patients
The potential risk for reinfection with COVID-19 remains a concern

Risk for COVID-19 Reinfection Remains Unknown

0
Jeffrey Shaman, Ph.D., of Climate and Health Program at Columbia University, spoke with HD Live! about COVID-19 reinfection risk
After reopening

Record-High Spikes in COVID-19 Cases Seen in Arizona, Florida, Texas

0
Why numbers are rising has become a point of argument between politicians and scientists